中文产业新闻精选评分80Chinese source
Revolution Medicines泛RAS抑制剂daraxonrasib获FDA批准用于经治转移性胰腺癌
治疗“癌症之王”迎来里程碑突破！FDA批准创新RAS靶向“分子胶”
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
治疗“癌症之王”迎来里程碑突破！FDA批准创新RAS靶向“分子胶”
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.